NCT06165666

Brief Summary

The World Health Organization (WHO) defines Stroke or Cerebrovascular Accident as clinical sign of focal disorder in brain functioning of rapid onset, with a presumed vascular origin and duration of more than 24 hours. It represents the first cause of physical disability in adults, and approximately half of people who survive stroke present motor and sensitivity disorders, which cause alterations in functionality, especially in activities of daily living, with the consequent impact negative in participation in the environment and the quality of life of people and their families. The objective of the study is to know the effectiveness of a Physiotherapy intervention, based on the achievement of objectives, in improving functionality, participation and quality of life after a Stroke compared to treatment protocol. Methodology: single-blind randomized controlled clinical trial. The sample of 62 subjects (31 in each group) will be recruited at the Ramon y Cajal University Hospital. The Physiotherapy intervention will consist of 30 sessions, 3 times/week, for 10 consecutive weeks, in which the treatment for the Experimental Group will be based on training of specific tasks aimed at functional objectives previously agreed upon with the person/user vs. the Control Group who will receive a conventional Physiotherapy treatment protocol. The outcome variables are: perception of quality of life (Spanish version of The Newcastle Stroke-specific Quality of Life Measure); degree of functional disability (Barthel Index); level of gait functionality (Spanish version of Functional Ambulation Categories); dynamic balance and trunk control (Spanish version of Trunk Impairment Scale); postural control (Spanish version of the Postural Assessment Scale for Stroke Patients); and participation in the environment (Spanish version of the Oxford Participation and Activities Questionnaire). They will be collected at three times: before starting the study, initial assessment (V0), at the end of the intervention for each group, intermediate assessment (V1) and 6 months after V0 (V2).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable stroke

Timeline
6mo left

Started Feb 2024

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Feb 2024Oct 2026

First Submitted

Initial submission to the registry

December 1, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 12, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Expected
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

1.2 years

First QC Date

December 1, 2023

Last Update Submit

May 30, 2024

Conditions

Keywords

strokephysiotherapyclinical trial

Outcome Measures

Primary Outcomes (3)

  • Perception of quality of life

    Spanish version of NewsQoL

    Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.

  • Functional disability

    Barthel index

    Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.

  • Participation in the environment

    Spanish version Oxford Participation and Activities Questionnaire

    Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.

Secondary Outcomes (3)

  • Level of gait functionality

    Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.

  • Dynamic balance and trunk control

    Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.

  • Postural control

    Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.

Other Outcomes (1)

  • Cognitive impairment

    Prior to inclusion in the study

Study Arms (2)

intervention group (EG)

EXPERIMENTAL

The participants will receive as a therapeutic approach 3 physical therapy sessions/week of 40' duration, for 10 weeks.

Other: Approach by functional objectives

control group (CG)

ACTIVE COMPARATOR

The participants will receive as a therapeutic approach 3 physical therapy sessions/week of 40' duration, for 10 weeks.

Other: Treatment protocol

Interventions

The therapeutic approach that will be administered to the EG will be based on the training of specific tasks aimed at functional objectives. Each session will begin with activities to activate the muscles of the trunk, pelvis and lower limbs, to modify atypical movement patterns and prepare the muscles for a more effective contraction. Subsequently, activity training will be carried out in a functional and meaningful context, aimed at specific and significant functional objectives for the participant and previously agreed upon with them.

intervention group (EG)

The therapeutic approach of the participants assigned to the CG will be aimed at maintaining joint ranges and transfer work, passive mobilization of the paretic lower and upper limb, maintenance of sitting posture with/without assistance, transfer from sitting to standing, from standing to sitting. and coordination work. Subsequently, initiation of walking with a support product and/or help, if possible.

control group (CG)

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with stroke between 6 and 24 months before the intervention.
  • Age 50 or more years.
  • Have signed the informed consent.

You may not qualify if:

  • Present moderate or severe cognitive impairment according to the Pfeiffer Questionnaire.
  • Have other serious diseases with a significant impact on functional capacity.
  • Suffer previously diagnosed psychiatric pathology.
  • Being dependent for activities of daily living before suffering the stroke.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Concepción Soto-Vidal

Alcalá de Henares, Madrid, 28871, Spain

Location

Related Publications (10)

  • Murie-Fernandez M, Irimia P, Martinez-Vila E, John Meyer M, Teasell R. [Neuro-rehabilitation after stroke]. Neurologia. 2010 Apr;25(3):189-96. Spanish.

    PMID: 20492866BACKGROUND
  • Wonsetler EC, Bowden MG. A systematic review of mechanisms of gait speed change post-stroke. Part 2: exercise capacity, muscle activation, kinetics, and kinematics. Top Stroke Rehabil. 2017 Jul;24(5):394-403. doi: 10.1080/10749357.2017.1282413. Epub 2017 Feb 20.

    PMID: 28218021BACKGROUND
  • Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, Tan BYQ. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-595. doi: 10.1007/s11239-020-02228-y.

    PMID: 32661757BACKGROUND
  • Alessandro L, Olmos LE, Bonamico L, Muzio DM, Ahumada MH, Russo MJ, Allegri RF, Gianella MG, Campora H, Delorme R, Vescovo ME, Lado V, Mastroberti LR, Butus A, Galluzzi HD, Decima G, Ameriso SF. [Multidisciplinary rehabilitation for adult patients with stroke]. Medicina (B Aires). 2020;80(1):54-68. Spanish.

    PMID: 32044742BACKGROUND
  • Kwakkel G, Stinear C, Essers B, Munoz-Novoa M, Branscheidt M, Cabanas-Valdes R, Lakicevic S, Lampropoulou S, Luft AR, Marque P, Moore SA, Solomon JM, Swinnen E, Turolla A, Alt Murphy M, Verheyden G. Motor rehabilitation after stroke: European Stroke Organisation (ESO) consensus-based definition and guiding framework. Eur Stroke J. 2023 Dec;8(4):880-894. doi: 10.1177/23969873231191304. Epub 2023 Aug 7.

    PMID: 37548025BACKGROUND
  • Leonardi M, Fheodoroff K. Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation. 2021 Jan 15. In: Platz T, editor. Clinical Pathways in Stroke Rehabilitation: Evidence-based Clinical Practice Recommendations [Internet]. Cham (CH): Springer; 2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK585584/

    PMID: 36315695BACKGROUND
  • Rosewilliam S, Roskell CA, Pandyan AD. A systematic review and synthesis of the quantitative and qualitative evidence behind patient-centred goal setting in stroke rehabilitation. Clin Rehabil. 2011 Jun;25(6):501-14. doi: 10.1177/0269215510394467. Epub 2011 Mar 25.

    PMID: 21441308BACKGROUND
  • Sugavanam T, Mead G, Bulley C, Donaghy M, van Wijck F. The effects and experiences of goal setting in stroke rehabilitation - a systematic review. Disabil Rehabil. 2013 Feb;35(3):177-90. doi: 10.3109/09638288.2012.690501. Epub 2012 Jun 7.

    PMID: 22671934BACKGROUND
  • Azevedo da Costa F, Araujo da Silva DL, da Rocha VM. [The functional condition of patients following a cerebrovascular accident]. Rev Neurol. 2006 May 16-31;42(10):591-5. Spanish.

  • Soto-Vidal C, Calvo-Fuente V, Hidalgo-Galante E, Cerezo-Tellez E, Perez-Martin Y, Pacheco-da-Costa S. Effectiveness of Physiotherapy for Improving Functionality, Participation, and Quality of Life after a Stroke: Study Protocol for a Randomized Controlled Clinical Trial. J Pers Med. 2024 Aug 22;14(8):891. doi: 10.3390/jpm14080891.

MeSH Terms

Conditions

Stroke

Interventions

Clinical Protocols

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Concepción Soto-Vidal

    University of Alcala

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Single-blind, parallel, randomized controlled clinical trial, allocation ratio 1:1 and with third-party evaluation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned into 2 groups (intervention group (EG) and control group (CG)).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Degree Teacher in Physiotherapy

Study Record Dates

First Submitted

December 1, 2023

First Posted

December 11, 2023

Study Start

February 12, 2024

Primary Completion

April 30, 2025

Study Completion (Estimated)

October 31, 2026

Last Updated

May 31, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations